Disc Medicine Management
Management criteria checks 3/4
Disc Medicine's CEO is John Quisel, appointed in Feb 2020, has a tenure of 4.33 years. total yearly compensation is $903.46K, comprised of 62.2% salary and 37.8% bonuses, including company stock and options. directly owns 0.009% of the company’s shares, worth $117.19K. The average tenure of the management team and the board of directors is 0.9 years and 3.7 years respectively.
Key information
John Quisel
Chief executive officer
US$903.5k
Total compensation
| CEO salary percentage | 62.2% |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.009% |
| Management average tenure | less than a year |
| Board average tenure | 3.7yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$81m |
| Dec 31 2023 | US$903k | US$562k | -US$76m |
| Sep 30 2023 | n/a | n/a | -US$64m |
| Jun 30 2023 | n/a | n/a | -US$66m |
| Mar 31 2023 | n/a | n/a | -US$60m |
| Dec 31 2022 | US$2m | US$476k | -US$47m |
| Sep 30 2022 | n/a | n/a | -US$44m |
| Jun 30 2022 | n/a | n/a | -US$37m |
| Mar 31 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$2m | US$455k | -US$36m |
| Dec 31 2020 | US$820k | US$373k | -US$21m |
Compensation vs Market: John's total compensation ($USD903.46K) is below average for companies of similar size in the US market ($USD5.68M).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
CEO
John Quisel (53 yo)
4.3yrs
Tenure
US$903,461
Compensation
Dr. John D. Quisel, J.D., Ph D., Esq., serves as Independent Director of Gossamer Bio, Inc. since November 2023. He serves as Chief Executive Officer of Disc Medicine, Inc. since February 25, 2020 and serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.2yrs | US$379.31k | 0.052% $ 665.5k | |
| CEO, President & Director | 4.3yrs | US$903.46k | 0.0091% $ 117.2k | |
| Chief Medical Officer | 2.8yrs | US$687.74k | 0.084% $ 1.1m | |
| Founder & Chair of Scientific Advisory Board | 6.7yrs | US$88.54k | 0.052% $ 675.6k | |
| Chief Financial Officer | less than a year | no data | 0.12% $ 1.6m | |
| Chief Opearating Officer | less than a year | US$816.54k | 0.061% $ 788.5k | |
| General Counsel | 2.5yrs | no data | 0.047% $ 609.3k | |
| Senior VP & Head of Chemistry | no data | no data | no data | |
| Senior Vice President of Nonclinical Development | 1.3yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | 0.12% $ 1.6m | |
| Senior VP of Quality | less than a year | no data | no data | |
| VP of Clinical Development & Head of Medical Affairs | less than a year | no data | no data |
0.9yrs
Average Tenure
54.5yo
Average Age
Experienced Management: IRON's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.2yrs | US$379.31k | 0.052% $ 665.5k | |
| CEO, President & Director | 4.3yrs | US$903.46k | 0.0091% $ 117.2k | |
| Founder & Chair of Scientific Advisory Board | less than a year | US$88.54k | 0.052% $ 675.6k | |
| Independent Director | 6.6yrs | US$268.31k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.7yrs | no data | no data | |
| Independent Director | 2.8yrs | US$264.31k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$266.81k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.7yrs | no data | no data | |
| Independent Director | 2.8yrs | US$262.81k | 0% $ 0 | |
| Independent Director | 3.5yrs | US$270.31k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
3.7yrs
Average Tenure
53yo
Average Age
Experienced Board: IRON's board of directors are considered experienced (3.7 years average tenure).